Evidence Report Now Available
Diagnostic Accuracy of Screening and Treatment of Post–Acute Coronary Syndrome Depression: A Systematic Review (Systematic Review, released 11/14/2017)
Selected key findings:
* The Beck Depression Inventory (BDI)-II screen tool is the most studied and is as accurate in this population as in others.
* Available depression-screening tools may miss 3 percent of people with depression, but less than 50 percent of those who screen positive have clinically confirmed depression.
* Enhanced care interventions that integrate psychiatric treatment into cardiology and primary care settings improve depression symptoms. Current evidence is insufficient to determine if enhanced care improves cardiac outcomes.
* Combining cognitive behavioral therapy and antidepressant medication may improve depression outcomes but does not clearly improve cardiac outcomes.
* For more, see https://
* For a related journal article, see http://annals.org/aim/
* Available depression-screening tools may miss 3 percent of people with depression, but less than 50 percent of those who screen positive have clinically confirmed depression.
* Enhanced care interventions that integrate psychiatric treatment into cardiology and primary care settings improve depression symptoms. Current evidence is insufficient to determine if enhanced care improves cardiac outcomes.
* Combining cognitive behavioral therapy and antidepressant medication may improve depression outcomes but does not clearly improve cardiac outcomes.
* For more, see https://
* For a related journal article, see http://annals.org/aim/
Opportunity to Comment on Draft Reports
We encourage the public to participate in the development of our research projects. Comments can be submitted for:
Psychological and Pharmacological Treatments for Adults With PTSD: A Systematic Review Update
Available for comment until December 28, 2017
Available for comment until December 28, 2017
About us: AHRQ’s Effective Health Care Program is committed to providing the best available evidence on the outcomes, benefits and harms, and appropriateness of drugs, devices, and health care services and by helping health care professionals, patients, policymakers, and health care systems make informed health care decisions. The program partners with research centers, academic institutions, health professional societies, consumer organizations, and other stakeholders to conduct research, evidence synthesis, evidence translation, dissemination, and implementation of research findings.
To learn more: https://www.
Contact us at: epc@ahrq.hhs.gov
.png)
No hay comentarios:
Publicar un comentario